BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29717197)

  • 1. Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial.
    Oduyebo I; Camilleri M; Nelson AD; Khemani D; Nord SL; Busciglio I; Burton D; Rhoten D; Ryks M; Carlson P; Donato L; Lueke A; Kim K; Rossi SJ; Zinsmeister AR
    Am J Gastroenterol; 2018 May; 113(5):725-734. PubMed ID: 29717197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.
    Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G508-16. PubMed ID: 25012842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.
    Rao AS; Wong BS; Camilleri M; Odunsi-Shiyanbade ST; McKinzie S; Ryks M; Burton D; Carlson P; Lamsam J; Singh R; Zinsmeister AR
    Gastroenterology; 2010 Nov; 139(5):1549-58, 1558.e1. PubMed ID: 20691689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation.
    Wong BS; Camilleri M; McKinzie S; Burton D; Graffner H; Zinsmeister AR
    Am J Gastroenterol; 2011 Dec; 106(12):2154-64. PubMed ID: 21876564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial.
    Acosta A; Camilleri M; Kolar G; Iturrino J; Szarka LA; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR; Spence SC; Gottesdiener K; Bouras EP; Vazquez-Roque MI
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2312-9.e1. PubMed ID: 26001337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
    Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea.
    Wong BS; Camilleri M; Carlson PJ; Guicciardi ME; Burton D; McKinzie S; Rao AS; Zinsmeister AR; Gores GJ
    Gastroenterology; 2011 Jun; 140(7):1934-42. PubMed ID: 21396369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
    Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.
    Camilleri M; Klee EW; Shin A; Carlson P; Li Y; Grover M; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G13-26. PubMed ID: 24200957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation.
    Bharucha AE; Low P; Camilleri M; Veil E; Burton D; Kudva Y; Shah P; Gehrking T; Zinsmeister AR
    Gut; 2013 May; 62(5):708-15. PubMed ID: 22677718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
    Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
    Vijayvargiya P; Busciglio I; Burton D; Donato L; Lueke A; Camilleri M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):522-527. PubMed ID: 28666948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea.
    Wong BS; Camilleri M; Carlson PJ; Odunsi-Shiyanbade S; McKinzie S; Busciglio I; Burton D; Zinsmeister AR
    Dig Dis Sci; 2012 May; 57(5):1222-6. PubMed ID: 22271411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
    Wong BS; Camilleri M; Carlson P; McKinzie S; Busciglio I; Bondar O; Dyer RB; Lamsam J; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1009-15.e3. PubMed ID: 22610000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.
    Hirschfield GM; Chazouillères O; Drenth JP; Thorburn D; Harrison SA; Landis CS; Mayo MJ; Muir AJ; Trotter JF; Leeming DJ; Karsdal MA; Jaros MJ; Ling L; Kim KH; Rossi SJ; Somaratne RM; DePaoli AM; Beuers U
    J Hepatol; 2019 Mar; 70(3):483-493. PubMed ID: 30414864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?
    Sweetser S; Camilleri M; Linker Nord SJ; Burton DD; Castenada L; Croop R; Tong G; Dockens R; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1299-306. PubMed ID: 19342506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
    Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation.
    Iturrino J; Camilleri M; Wong BS; Linker Nord SJ; Burton D; Zinsmeister AR
    Aliment Pharmacol Ther; 2013 Apr; 37(8):776-85. PubMed ID: 23451764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans.
    Coulie B; Szarka LA; Camilleri M; Burton DD; McKinzie S; Stambler N; Cedarbaum JM
    Gastroenterology; 2000 Jul; 119(1):41-50. PubMed ID: 10889153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.